DongKook Pharmaceutical Co Ltd
086450
Company Profile
Business description
DongKook Pharmaceutical Co Ltd is a part of the healthcare industry based in Korea. Being a pharmaceutical company, its activities are focused on the research and development of drugs. The company produces superior medicines used favorably by consumers such as Madecassol, which is a drug for wounds and Oramedy, which is a drug for treating stomatitis. It also owns a prefilled syringe system in its second factory, through which it produces various kinds of ultramodern injection agents.
Contact
Dongkook Building 997-8 Daechi 3-dong
Kangnam-gu
Seoul135-502
KORT: +82 221919850
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,269
Stocks News & Analysis
stocks
Are small caps finally back?
Does renewed investor interest point to a structural shift in the underperforming factor?
stocks
Chart of the Week: Modest earnings growth at odds with overvalued bank shares
The latest update from our Industry Pulse report.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,321.10 | 10.80 | -0.12% |
| CAC 40 | 8,206.87 | 51.99 | -0.63% |
| DAX 40 | 24,151.13 | 178.90 | -0.74% |
| Dow JONES (US) | 46,590.41 | 334.33 | -0.71% |
| FTSE 100 | 9,515.00 | 88.01 | 0.93% |
| HKSE | 25,781.77 | 245.78 | -0.94% |
| NASDAQ | 22,740.40 | 213.27 | -0.93% |
| Nikkei 225 | 49,307.79 | 8.27 | -0.02% |
| NZX 50 Index | 13,303.28 | 3.16 | -0.02% |
| S&P 500 | 6,699.40 | 35.95 | -0.53% |
| S&P/ASX 200 | 9,030.00 | 10.30 | -0.11% |
| SSE Composite Index | 3,913.76 | 2.57 | -0.07% |